Study: Dual treatment of chronic lung diseases increases risk of heart attack

People using two different inhalers for common chronic lung diseases are more than 50 percent more likely to have a heart attack than those on just one, new University of Otago-led research reveals. Inhaled long-acting muscarinic antagonists (LAMAs) and long-acting beta-agonists (LABAs) are the main drugs used to treat chronic obstructive pulmonary disease (COPD) – […]

Continue Reading